Total planned funding: $976,751,213
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $976,751,213 |
Organizational Types
Unknown | $252,106,207 |
Private Contractor | $202,416,185 |
NGO | $178,857,857 |
University | $121,832,542 |
Own Agency | $98,398,926 |
Implementing Agency | $75,606,645 |
FBO | $38,661,568 |
Other USG Agency | $4,433,283 |
Host Country Government Agency | $3,250,000 |
Multi-lateral Agency | $1,188,000 |
Program Areas
Treatment | $418,491,324 |
Care | $187,597,166 |
Prevention | $136,859,167 |
Governance and Systems | $130,177,190 |
Management and Operations | $75,377,367 |
Testing | $28,248,999 |
Budget Codes
HTXD: Treatment: ARV Drugs | $221,925,874 |
HTXS: Treatment: Adult Treatment | $184,225,582 |
HKID: Care: Orphans and Vulnerable Children | $87,525,557 |
HVMS: Management and Operations | $75,377,367 |
HBHC: Care: Adult Care and Support | $68,732,924 |
HLAB: Laboratory Infrastructure | $62,881,713 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $51,668,610 |
HVSI: Strategic Information | $42,261,752 |
HVOP: Sexual Prevention: Other Sexual Prevention | $31,760,156 |
HVCT: Testing: HIV Testing and Counseling | $28,248,999 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $27,259,714 |
OHSS: Health Systems Strengthening | $25,033,725 |
HVTB: Care: TB/HIV | $20,876,332 |
HMBL: Biomedical Prevention: Blood Safety | $14,941,244 |
PDTX: Treatment: Pediatric Treatment | $12,339,868 |
HMIN: Biomedical Prevention: Injection Safety | $11,229,443 |
PDCS: Care: Pediatric Care and Support | $10,462,353 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$190,801,140
Countries/Regions
FHI 360:
$106,324,523
Countries/Regions
USG Aggregated Agencies:
$81,571,275
Countries/Regions